For citations:

Tolmacheva E.A., Pashkova E.N. Lenvatinib and pembrolizumab combination in recurrent endometrial cancer: regional experience. Medical alphabet. 2025;(11):76-79. (In Russ.) https://doi.org/10.33667/2078-5631-2025-11-76-79